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INTRODUCTION 52
Tuberculosis (TB) is a global public health problem, with about 9 million new infections 53 and 1.5 deaths occurring in a year. 1 People living with HIV (PLHIV) comprised 13% of all TB 54 deaths. However, there is limited data on the contribution of TB in adolescents to the global TB 55 burden. In fact, lack of adolescent-specific health data is a global challenge. 2 Older 56 epidemiologic data suggest increased incidence of TB during adolescence 3, 4 , and the risk of TB 57 infection is highest during infancy and adolescence. [5] [6] [7] More recent data suggested high 58 prevalence of TB among adolescents aged 12-18 years. 8
59
Since adolescents are socially active, their potential to transmit to their peers is high and 60 risk factors such as smoking, substance use, and stress are more common among adolescents 61 increasing their likelihood of developing TB and eventually transmitting to their peers. 9-11 Also, 62 with more and more perinatally HIV infected children growing to adolescence, it is important to 63 have clearer understanding of both the magnitude and factors contributing to TB incidence in this 64 age group in order to plan for appropriate preventive measures. 10, 11 65 Data on the magnitude and determinants of TB among adolescents are scarce and when 66 reported, they are not generally focused on HIV infected adolescents or separately report on the 67 age group 10-19 years of age. 8, [12] [13] [14] Our objective was to determine the magnitude of TB among 68 adolescents at each phase of HIV care cascade in a cohort of ALHIV treated and followed at 69 selected public health facilities in Ethiopia. 15 70 71
METHODS

72
Study setting 73 This study was conducted in eight health facilities in Addis Ababa and Southern 74 Nations', Nationalities' and Peoples' Regional State (SNNPR) regions of Ethiopia. Addis Ababa 75 is the capital city of Ethiopia whereas SNNPR is a predominantly rural region, although most of 76 HIV patients are concentrated in urban areas even in SNNPR. The eight health facilities were 77 selected based on the high load of ALHIV, according to the investigators' prior knowledge about 78 the sites. Despite the good progress made in preventing and controlling HIV and TB, Ethiopia 79 belongs to high HIV and TB burden countries. 16, 1 80 Study design 81 We used a retrospective cohort study design. The study population constituted tests. The first line diagnostic test during the cohort period was conventional sputum microscopy.
88
Chest radiography was done on selected cases upon physicians' recommendation. Rapid TB 89 diagnostic tests were not part of the national guidelines at the time this cohort was enrolled. 17
90
To calculate the sample size, we used the baseline WHO clinical stage as main predictor 91 of TB and those in stage III-IV were considered "exposed" groups. Assuming a two-sided alpha 92 of 0.05, power of 0.8, TB in the exposed group as 10%, and TB in the unexposed group as 5%, 93 we calculated minimum sample size of 948. The assumptions were based on preliminary 94 analyses of data from ongoing larger cohort study in the study site. Using an electronic access 95 database maintained at each ART clinic, we generated age-stratified list of patients as a sampling 96 frame. Since the number of eligible adolescents was close to the estimated sample size, we 97 included all eligible adolescents in the study.
98
Data collection and management 99 We used patient charts and registers as data sources. At each site, two study nurses 100 assisted by data clerks retrieved information using a data abstraction form. At the end of each 101 work week, the site study nurses submitted all completed data abstraction forms to the co-102 investigator in the respective region. The co-investigator, who is a pediatrician with specialist 103 level training in HIV, checked for errors and omissions and forwarded the paper data forms to 104 the centrally based research assistant for further quality check and for secure storage. A centrally 105 based data clerk entered data from checked and approved data abstraction forms into SPSS 106 version 22.0. Electronic data were stored in a password protected data storage device and the 107 paper data forms were kept in a lockable shelf. No patient identifiers were included in the 108 electronic data.
109
The data abstraction tool was piloted in a few sites before starting actual data abstraction.
110
All staff involved in data management were trained on the standard operating procedures of the 111 study protocol. The principal author did random checks of the completed data abstraction forms 112 at regular intervals. Patients in whom TB diagnosis was confirmed at least four weeks after the patient was in pre-
117
ART care but before the ART start date were defined to have pre-ART TB. Patients who 118 developed TB after four weeks of ART initiation were considered to have TB during ART. 119 We determined IPT completion rates from patient registers. Those who completed a 6-120 month course of IPT and labelled by the clinicians as such were considered "completed"; those 121 who received for less than 6 months were categorized as "did not complete"; and those with 122 missing information were categorized as "no information".
123
Information on adherence to co-trimoxazole therapy (CPT) was also retrieved from 124 patient registers. Clinicians recorded either "good" or "poor" based on patients' self-report. We 125 determined the adherence status as per the clinician's record during the patients' last visit.
126
Data analysis 127 We used SPSS version 22 for data analysis. We calculated TB incidence rate as number This is the first report of ALHIV-specific TB data from Ethiopia and perhaps one of a 181 few globally. We found a high TB incidence rate among ALHIV, especially during pre-ART and 182 the first year of ART, and declined sharply after the first year of ART. Low baseline CD4 values, 183 advanced clinical disease stage, previous history of TB, and presence of prolonged cough at 184 baseline predicted occurrence of TB. IPT was associated with 94% reduction in TB incidence 185 rate in the ART cohort. Our findings suggest the need to prioritize ALHIV for TB prevention and 186 highlight the need to be watchful for specific risk factors during clinical care of adolescents.
RESULTS
187
Both the pre-ART and after ART TB rates in our cohort are at least ten times higher than 188 those reported among non-HIV infected adolescents. In a rural Uganda, for example, the 189 incidence of TB among adolescents aged 12-18 years was 0.235 per 100 PYO. 13 Among 190 adolescents in a South African school, TB incidence rate was 0.45 per 100 PYO. 18
191
The pre-ART TB incidence rate in our study is higher than what was reported in adult 192 cohorts from similar settings. In two reports from southern Ethiopia, pre-ART TB incidence 193 ranged from 9.9-11.1 per 100 PYO. 19, 20 However, the overall TB incidence rate of 2.25 per 100 194 PYO in adolescents who received ART in our study is lower than a rate of 3.7 per 100 PYO in an The predictive value of CD4 count and WHO clinical stage are well documented in adult 202 cohorts. 23, 24 We found similar results in the pre-ART cohort but we did not find significant 203 association between TB incidence and WHO clinical stage after ART. This suggests that CD4 204 count may be a more reliable predictor of TB incidence in the adolescent cohort compared with 205 the WHO clinical stage.
206
Despite its proven effectiveness, IPT coverage was low in this age group. Our finding 207 concurs with results from similar settings. This further confirms the need to strengthen IPT 208 implementation. 24
209
The higher TB incidence rate among ART patients from SNNPR was an unexpected 210 finding. It could be a reflection of variations in disease burden or a result of differences in case 211 finding efforts. Further analysis of epidemiologic data is needed to better explain the regional 212 variations. .
213
Previous history of TB was associated with more than doubling in the risk of TB in this 214 cohort. Earlier studies among adult cohorts reported conflicting results 22, but a more recent study 215 from Brazil reported doubling in the risk of TB in patients who had previous history of TB, and 216 about 38% of the patients in that report had previous history of TB. 26 In our cohort, about 46% of 217 patients who developed TB during pre-ART follow up had previous history of TB which could 218 be due to the higher overall TB burden in Ethiopia. 1 Reinfection due to weakened immune status 219 is the underlying reason for TB recurrence in PLHIV. 27, 28 Since our cohort includes patients 220 from pre-ART era over a decade ago, they might have had TB and treatment for it long before 221 starting ART. Our finding suggests the need for including previous history of TB as part of the 222 routine screening checklists in high TB/HIV burden settings.
223
Our study has some limitations. TB diagnosis was made based on microscopy or 224 radiography potentially leading to underestimation of incident TB cases because of the low 225 sensitivity of the diagnostic method. Because of the retrospective data collection method, we 226 were not able to determine the outcomes of treated TB cases and data were missing on some key 227 potential predictors such as smoking. Nevertheless, to our knowledge these are the first 228 adolescent-specific TB data among PLHIV in Ethiopia and likely will have broader implications 229 with increasing numbers of HIV-infected adolescents globally. 230 231 CONCLUSIONS 232 We found a high rate of TB incidence among ALHIV in public health facilities in two 233 regions of Ethiopia. IPT and ART had protective effect. However, the IPT coverage rate was 234 unacceptably low in this age group. The first year of ART was the period with highest rates of 235 incident TB cases followed by the pre-ART period. TB programs should prioritize ALHIV as 236 priority target groups for TB prevention and control efforts, especially up to the first year after 237 ART. Strengthening school TB programs, contact investigation among adolescents, early IPT 238 and adequate IPT coverage should be considered urgent priorities. Prospective studies with more 239 comprehensive variables will provide further insights about the high TB rate in this age group.
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